- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
GW4064是一種farnesoid X receptor (FXR)激動劑,CV1細胞系中EC50為65 nM。濃度達到1 μM時,對其他核受體沒有活性。GW4064在MCF-7細胞中可刺激自噬。
GW4064 Chemical Structure
CAS: 278779-30-9
規(guī)格 | 價格 | 庫存 | 購買數(shù)量 |
---|---|---|---|
10mM (1mL in DMSO) | 790 | 現(xiàn)貨 | |
5mg | 571.57 | 現(xiàn)貨 | |
25mg | 2220.65 | 現(xiàn)貨 | |
50mg | 3013.36 | 現(xiàn)貨 | |
1g | 23751 | 現(xiàn)貨 | |
更大包裝 有超大折扣 | |||
400-668-6834 |
|||
相關產(chǎn)品 | Guggulsterone E&Z Turofexorate Isopropyl (XL335) | 點擊展開 |
---|---|---|
相關化合物庫 | 代謝化合物庫 抗癌代謝化合物庫 谷氨酰胺代謝化合物庫 糖代謝化合物庫 脂代謝化合物庫 | 點擊展開 |
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
HepG2 | Function assay | 1 uM | 18 hrs | Decrease in CYP7A1 gene expression in human HepG2 cells at 1 uM after 18 hrs by RT-PCR | 17963371 |
Caco-2 | Function assay | 1 uM | 6 days | Activation of IBABP gene expression in human Caco-2 cells at 1 uM after 6 days by RT-PCR | 17963371 |
HepG2 | Function assay | 1 uM | 18 hrs | Activation of BSEP gene expression in human HepG2 cells at 1 uM after 18 hrs by RT-PCR | 17963371 |
Huh7 | Function assay | 1 uM | 18 hrs | Activation of SHP gene expression in human Huh7 cells at 1 uM after 18 hrs by RT-PCR | 17963371 |
Huh7 | Function assay | 1 uM | 18 hrs | Activation of BSEP gene expression in human Huh7 cells at 1 uM after 18 hrs by RT-PCR | 17963371 |
HepG2 | Function assay | 10 uM | 10 mins | Induction of FXR-mediated Akt-phosphorylation at S473 site in serum-starved human HepG2 cells at 10 uM measured after 10 mins by western blot analysis | 27372840 |
HepG2 | Function assay | 10 uM | 10 mins | Induction of FXR-mediated Akt-phosphorylation in serum-starved human HepG2 cells assessed as increase in GSK-3beta-phosphorylation at 10 uM measured after 10 mins by western blot analysis | 27372840 |
HepG2 | Function assay | 10 uM | Induction of FXR-mediated SHP mRNA expression in serum-starved human HepG2 cells at 10 uM measured after overnight incubation by qPCR analysis | 27372840 | |
HepG2 | Function assay | 10 uM | Activation of FXR in human HepG2 cells assessed as upregulation of SHP mRNA expression at 10 uM by RT-PCR method | 30031618 | |
HepG2 | Function assay | 10 uM | Activation of FXR in human HepG2 cells assessed as upregulation of FXR mRNA expression at 10 uM by RT-PCR method | 30031618 | |
HepG2 | Function assay | 10 uM | Activation of FXR in human HepG2 cells assessed as downregulation of SREBP-1c mRNA expression at 10 uM by RT-PCR method | 30031618 | |
3T3L1 | Function assay | 10 uM | Reduction in lipid accumulation in mouse 3T3L1 cells at 10 uM by Oil Red O staining-based absorbance method relative to control | 30342957 | |
HeLa | Function assay | 24 hrs | Agonist activity at human full length FXR expressed in HeLa cells cotransfected with pSG5-human RXR after 24 hrs by Dual-Glo luciferase reporter gene assay, EC50 = 0.51 μM. | 25934227 | |
insect cells | Function assay | 1 hr | Agonist activity at recombinant human GST-tagged FXR ligand binding domain (193 to 472 residues) expressed in baculovirus infected insect cells assessed as induction of interaction with biotin labelled SRC-1 after 1 hr by HTRF assay, EC50 = 0.019 μM. | 29148806 | |
HEK293T | Function assay | 24 hrs | Agonist activity at human FXR expressed in HEK293T cells assessed as BSEP promoter driven cellular transcriptional activity after 24 hrs by luciferase reporter gene assay, EC50 = 0.095 μM. | 29148806 | |
HEK293 | Function assay | Agonist activity at human GST-fused FXR LBD expressed in HEK293 cells coexpressing GAL4-DNA bindig domain and pFRluc by mammalian one-hybrid assay, EC50 = 0.035 μM. | 20638278 | ||
HEK293 | Function assay | Agonist activity at human full length FXR transfected in HEK293 cells coexpressing pTRexDest/pGL2promotor assessed as luciferase activity by direct reporter cellular assay, EC50 = 0.03 μM. | 20638278 | ||
CV1 | Function assay | Increase in human FXR-mediated transient transcription of luciferase reporter gene transfected in african green monkey CV1 cells, EC50 = 0.065 μM. | 19586769 | ||
CV1 | Function assay | Agonist activity at human FXR transfected in african green monkey CV1 cells by luciferase reporter gene transient transfection assay, EC50 = 0.065 μM. | 19410460 | ||
CV1 | Function assay | Agonist activity at FXR expressed in african green monkey CV1 cells by luciferase reporter transient transfection assay, EC50 = 0.065 μM. | 18621523 | ||
HEK293 | Function assay | Agonistic activity at FXR in HEK293 cells by GAL4 transactivation activity, EC50 = 0.07 μM. | 17292610 | ||
CV-1 | Function assay | Agonist activity at human FXR LBD iexpressed in monkey CV-1 cells assessed as transactivation of luciferase reporter gene expression, EC50 = 0.065 μM. | 21256005 | ||
CV1 | Function assay | Agonist activity at human FXR LBD transfected in african green monkey CV1 cells after overnight incubation by luciferase reporter gene assay, EC50 = 0.065 μM. | 21890356 | ||
HEK293 | Function assay | Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N by luciferase reporter gene assay, EC50 = 0.07 μM. | 22583617 | ||
HEK293 | Function assay | Agonist activity at human FXR expressed in HEK293 cells by luciferase reporter gene assay, EC50 = 0.026 μM. | 25305688 | ||
CV1 | Function assay | Agonist activity at FXR (unknown origin) transfected into african green monkey CV1 cells assessed as ligand-mediated transcription by luciferase reporter/ transient transfection assay, EC50 = 0.065 μM. | 25499883 | ||
HEK293 | Function assay | Agonist activity at human FXR transfected in HEK293 cells assessed as transcriptional activity by luciferase reporter gene assay, EC50 = 0.373 μM. | 26568144 | ||
HEK-293 | Function assay | Agonist activity at C-terminal Gal4-tagged human FXR (187 to 472 residues) expressed in HEK-293 cells co-expressing pFRluc by mammalian one hybrid assay, EC50 = 0.035 μM. | 27268696 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | GW4064是一種farnesoid X receptor (FXR)激動劑,CV1細胞系中EC50為65 nM。濃度達到1 μM時,對其他核受體沒有活性。GW4064在MCF-7細胞中可刺激自噬。 | ||
---|---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | GW 4064是一種完全激動劑,在轉染有鼠源和人源FXR表達載體以及確定的報告基因的CV-1細胞中, EC50分別為80和90。GW 4064直到1 μM濃度對其它核受體也沒有活性,包括維甲酸受體。因此, GW 4064是一種強有效和選擇性的非類固醇FXR激動劑[2]。 |
|||
---|---|---|---|---|
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | PTEN / p-AKT / AKT p-EGFR / EGFR / p-ERK / ERK / p-Src / Src SOCS3 / p21 / p-STAT3 / STAT3 |
![]() |
25187826 | |
Growth inhibition assay | Cell proliferation |
![]() |
25187826 |
體內(nèi)研究(In Vivo) | ||
體內(nèi)研究活性 | 大鼠體內(nèi)藥代動力學實驗顯示GW 4064口服生物利用度為10%,t1/2 = 3.5小時。 Fisher大鼠按劑量填喂給藥。7天之后, GW 4064處理的大鼠血清甘油三酯下降并具有劑量依賴特性,ED50 = 20 mg/kg[2]。 |
|
---|---|---|
動物實驗 | Animal Models | Fisher大鼠 |
Dosages | 0-100 mg/kg | |
Administration | 口服, 一天兩次 |
分子量 | 542.84 | 分子式 | C28H22Cl3NO4 |
CAS號 | 278779-30-9 | SDF | Download GW4064 SDF |
Smiles | CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC(=C(C=C3)C=CC4=CC(=CC=C4)C(=O)O)Cl | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 100 mg/mL ( (184.21 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Water : Insoluble Ethanol : Insoluble |
摩爾濃度計算器 |
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 |
動物體內(nèi)配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項